Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SNY
Recent news which mentions SNY
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
26
27
Next >
Earnings Scheduled For April 27, 2023
April 27, 2023
Tickers
OPRA
ORC
ORI
OSK
Tags
OPRA
PPBI
PEAK
From
Benzinga
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
April 27, 2023
Tickers
AAL
ABBV
AMGN
AMZN
Tags
MA
CMCSA
MAT
From
Benzinga
Earnings Outlook For Sanofi
April 26, 2023
Tickers
SNY
Tags
Benzinga
Earnings
Market News
From
Benzinga
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
April 24, 2023
Tickers
BAYRY
GSK
HLN
INTC
Tags
IPOs
PG
MBLY
From
Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
April 21, 2023
Tickers
GSK
MRK
SNY
TAK
Tags
Market News
Contracts
MRK
From
Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
April 19, 2023
Tickers
EWTX
IPHA
PRVB
SGEN
Tags
PRVB
Benzinga
Biotech
From
Benzinga
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
April 18, 2023
Tickers
AMGN
AZN
BIIB
BLUE
Tags
SNY
NVO
AMGN
From
Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
April 12, 2023
Tickers
PRVB
SNY
TLSA
Tags
Market News
Partner Content
TLSA
From
Benzinga
Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
April 11, 2023
Tickers
PRVB
SNY
Tags
Large Cap
News
SNY
From
Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
Tickers
BGNE
BMY
CRMD
DD
Tags
BGNE
CRMD
Market News
From
Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
April 11, 2023
Tickers
BGNE
BMY
CRMD
DD
Tags
SNY
JNJ
HILS
From
Benzinga
2 Top Healthcare Stocks Defying the Bear Market
April 07, 2023
Tickers
MCK
SNY
Tags
SNY
MCK
Market News
From
Motley Fool
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
April 06, 2023
Tickers
LLY
MRK
NVO
SNY
Tags
Recent Press Releases
Market News
LLY
From
Motley Fool
Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity?
March 30, 2023
Tickers
REGN
SNY
Tags
SNY
REGN
Market News
From
Motley Fool
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
March 25, 2023
Tickers
REGN
SNY
Tags
SNY
REGN
Market News
From
Motley Fool
Is Sanofi Stock a Buy Now?
March 25, 2023
Tickers
PRVB
SNY
Tags
SNY
PRVB
Recent Press Releases
From
Motley Fool
Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In
March 24, 2023
Tickers
REGN
SNY
Tags
Evan Seigerman
Raymond James
SNY
From
Benzinga
Regeneron Pharmaceuticals Options Traders Betting On Stock Falling This Much By April Expiration
March 24, 2023
Tickers
REGN
SNY
Tags
Media
CNBC
Options Action
From
Benzinga
Looking Into Sanofi's Recent Short Interest
March 23, 2023
Tickers
SNY
Tags
SNY
Short Ideas
Trading Ideas
From
Benzinga
Why Shares of Regeneron Are Rising Thursday
March 23, 2023
Tickers
REGN
SNY
Tags
Recent Press Releases
Market News
SNY
From
Motley Fool
REGN Stock Alert: Regeneron Pharmaceuticals Gains on Dupixent Drug Data
March 23, 2023
Tickers
ACN
COIN
REGN
SNY
Tags
ACN
REGN
Today's Market
From
InvestorPlace
Apple Jumps Movie Production Bandwagon, Billionaire Jim Ratcliffe Bids For Manchester United, Elon Musk Seeks Funding For SpaceX From Middle-Eastern Fund: Today's Top Stories
March 23, 2023
Tickers
AAPL
AMZN
DAL
GBIO
Tags
General
AAPL
Media
From
Benzinga
Why Regeneron Pharmaceuticals And Sanofi Shares Are Trading Higher Today
March 23, 2023
Tickers
REGN
SNY
Tags
SNY
Briefs
Large Cap
From
Benzinga
Coinbase’ stock tumbles on SEC warning, while First Republic and Regeneron shares rally, and other stocks on the move
March 23, 2023
Tickers
ACN
CHWY
COIN
FRC
Tags
FR:SAN
ACN
REGN
From
MarketWatch
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
March 20, 2023
Tickers
BBBY
CS
CSLLY
EADSF
Tags
General
Media
NYT
From
Benzinga
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
March 20, 2023
Tickers
CSLLY
GSK
MRNA
SNY
Tags
Benzinga
Health Care
GSK
From
Benzinga
Acer Therapeutics' Product Acquired From Sanofi Fails In Menopause Study
March 17, 2023
Tickers
ACER
SNY
Tags
Market News
General
Benzinga
From
Benzinga
SVB Financial Officially Files For Bankruptcy, Yellen, Powell & Dimon Behind First Republic Bank's $30B Lifeline, Playboy's $5M Loss On Ethereum: Today's Top Stories
March 17, 2023
Tickers
ACIW
ASTR
BIDU
C
Tags
Tech
News
Top Stories
From
Benzinga
Three Is Company - Sanofi Follows Lilly, Novo Nordisk, Slashes Insulin Product Price By 78%
March 17, 2023
Tickers
LLY
NVO
SNY
Tags
Biotech
NVO
LLY
From
Benzinga
Why Provention Bio Stock Skyrocketed 256% This Week
March 16, 2023
Tickers
PRVB
SNY
Tags
PRVB
SNY
Market News
From
Motley Fool
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.